Literature DB >> 35974199

An ultrasensitive hairpin sensor based on g-C3N4 nanocomposite for the detection of miRNA-155 in breast cancer patient serum.

Pingping Peng1,2, Sheng Wang3, Siyuan Cai4, Jing Cheng2, Dan Tao5, Nicole Jaffrezic-Renault6, Zhenzhong Guo7.   

Abstract

Achieving the early diagnosis of breast cancer, through ultrasensitive detection of tumor marker miRNA-155, is a significant challenge. Therefore, an ultrasensitive hairpin electrochemical biosensor based on graphite-like phase carbon nitride composite was proposed. In this paper, poly(D-glucosamine) (PDG) was used as a stabilizer and reducing agent to prepare gold nanoparticles at room temperature, and then a graphite-like phase with a two-dimensional lamellar structure carbon nitride was further combined with it to obtain the poly(D-glucosamine)/gold nanoparticles/graphite-like phase carbon nitride nanocomposite (PDG/AuNPs/g-C3N4), in order to achieve the goal of signal amplification. The specific hairpin capture probe (HP) that recognized and bound miRNA-155 was then grafted. The hairpin biosensor showed a linear range of 0.1 fM-1 pM with a detection limit of 0.05 fM using differential pulse voltammetry (DPV) electrochemical analysis. Furthermore, the excellent performance hairpin electrochemical biosensor had been applied to the detection of miRNA-155 in human serum samples with good recovery.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Breast cancer; Hairpin electrochemical biosensor; Human serum samples; Poly(D-glucosamine)/gold nanoparticles/carbon nitride; miRNA-155

Mesh:

Substances:

Year:  2022        PMID: 35974199     DOI: 10.1007/s00216-022-04284-0

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  24 in total

1.  MicroRNA detection by northern blotting using locked nucleic acid probes.

Authors:  Eva Várallyay; József Burgyán; Zoltán Havelda
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 2.  miRNA dysregulation in breast cancer.

Authors:  Laoighse Mulrane; Sharon F McGee; William M Gallagher; Darran P O'Connor
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

3.  MicroRNA expression profiling using microarrays.

Authors:  Chang-Gong Liu; George Adrian Calin; Stefano Volinia; Carlo M Croce
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 4.  Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease.

Authors:  Marcelo A Mori; Raissa G Ludwig; Ruben Garcia-Martin; Bruna B Brandão; C Ronald Kahn
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

5.  Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.

Authors:  Menha Swellam; Amal Ramadan; Enas A El-Hussieny; Noha M Bakr; Naglaa M Hassan; Mohamed Emam Sobeih; Lobna R EzzElArab
Journal:  J Cell Biochem       Date:  2019-03-01       Impact factor: 4.429

6.  Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.

Authors:  Alba Rodríguez-Martínez; Diego de Miguel-Pérez; Francisco Gabriel Ortega; José Luis García-Puche; Inmaculada Robles-Fernández; José Exposito; Jordi Martorell-Marugan; Pedro Carmona-Sáez; María Del Carmen Garrido-Navas; Christian Rolfo; Hugh Ilyine; José Antonio Lorente; Marta Legueren; María José Serrano
Journal:  Breast Cancer Res       Date:  2019-02-06       Impact factor: 6.466

Review 7.  Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.

Authors:  Mohammad Azam Ansari; Muthu Thiruvengadam; Zeba Farooqui; Govindaswamy Rajakumar; Qazi Mohammad Sajid Jamal; Mohammad A Alzohairy; Ahmad Almatroudi; Mohammad N Alomary; Ill-Min Chung; Ebtesam Abdullah Al-Suhaimi
Journal:  Semin Cancer Biol       Date:  2019-12-28       Impact factor: 15.707

8.  Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling.

Authors:  Kang Kang; Xiao Peng; Jun Luo; Deming Gou
Journal:  J Anim Sci Biotechnol       Date:  2012-02-28

9.  Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.

Authors:  W Kong; L He; E J Richards; S Challa; C-X Xu; J Permuth-Wey; J M Lancaster; D Coppola; T A Sellers; J Y Djeu; J Q Cheng
Journal:  Oncogene       Date:  2013-01-28       Impact factor: 9.867

Review 10.  The network of non-coding RNAs and their molecular targets in breast cancer.

Authors:  Francesca Crudele; Nicoletta Bianchi; Eva Reali; Marco Galasso; Chiara Agnoletto; Stefano Volinia
Journal:  Mol Cancer       Date:  2020-03-18       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.